A Retrospective Analysis of Percutaneous Endoscopic Gastrostomy Experiences
1 other identifier
observational
52
1 country
2
Brief Summary
The application of PEG in geriatric-palliative care has not been well discussed. With the development of endoscopic procedures and PEG devices, we can perform this minimally invasive method more safely, even in challenging cases. We should discuss the indications of PEG in the field of palliative care of geriatric patients. The presented study evaluated geriatric (\> 65-year-old) palliative care patients to whom PEG applied at our institution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2017
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
October 2, 2021
CompletedFirst Posted
Study publicly available on registry
October 13, 2021
CompletedOctober 13, 2021
October 1, 2021
3.2 years
October 2, 2021
October 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Weight and body mass index changes
Evaluation of weight and body mass index changes after Percutaneous endoscopic gastrostomy tube application
30 days
Interventions
Percutaneous endoscopic gastrostomy (PEG) is a minimally-invasive endoscopic procedure that creates a passage from the patient's stomach to the abdominal wall via a feeding tube and provides a means of feeding if oral intake is not adequate.
Eligibility Criteria
We retrospectively assessed the medical data of PEG applied \>65-year-old patients at our institution between December 2017 and March 2021. And, we excluded the patients who were not treated in our palliative care center. Table 1. shows the contraindications for PEG placement.
You may qualify if:
- \- We retrospectively assessed the medical datum of PEG applied \>65-year-old patients at our institution between December 2017 and March 2021 in our clinic.
You may not qualify if:
- We excluded the patients who were not treated in our palliative care center.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Okan Universitylead
Study Sites (2)
Okan University Hospital
Istanbul, 34734, Turkey (Türkiye)
Okan University
Istanbul, 34734, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Murat Ferhat Ferhatoglu, MD
Okan
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 2, 2021
First Posted
October 13, 2021
Study Start
December 1, 2017
Primary Completion
March 1, 2021
Study Completion
March 1, 2021
Last Updated
October 13, 2021
Record last verified: 2021-10